🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Skin elasticity changes during sema weight loss — 12 month update Page 3

Skin elasticity changes during sema weight loss — 12 month update

quinn_sf Thu, May 2, 2024 at 11:40 PM 13 replies 1,993 viewsPage 3 of 3
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
May 8, 2024 at 4:37 PM#11
Dr.BariatricHTX said:
If two explanations both fit, the useful question is which one predicts something the other does not.

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

I would rather be corrected than agreed with, if it comes to it.

19 17kim_atl_prep, sarah_TO, wendy_avl and 16 others
Reply Quote Save Share Report
denise_HTX
Member
145
678
Jan 2025
Houston, TX
May 9, 2024 at 8:18 AM#12
hyun_seoul said:
The mechanism that matters here is not stomach emptying, it is central.

This is exactly what I could not find anywhere else. Taking it to my next appointment.

20 18NeuroNate, JessicaH_TX, KevinCompounds and 17 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
May 9, 2024 at 11:59 PM#13
Dr.BariatricHTX said:
If two explanations both fit, the useful question is which one predicts something the other does not.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

21 19Dr.NateNeph, PharmD_Rodriguez, julia.endo and 18 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
May 10, 2024 at 3:39 PM#14

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

22 20Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 19 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 11, 2024 at 7:19 AM#15

Moderator note: a couple of off-topic posts removed.

Last edited: May 11, 2024 at 9:19 AM
23 21PurityPaulOR, MaxMetOK, MounjBrad and 20 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register